<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mantle cell (centrocytic) <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e>) and occasional cases of B-cell small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>/<z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (B-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SLL</z:e>/CLL) show a characteristic translocation, t(11:14)(q13;q32) involving rearrangement of the Bcl-1 region </plain></SENT>
<SENT sid="1" pm="."><plain>Recently it was shown that the key Bcl-1 region oncogene is cyclin D1/PRAD1; cyclin D1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> was shown to be overexpressed in cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We examined cyclin D1 protein expression in low-grade B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and reactive <z:mp ids='MP_0000688'>lymphoid hyperplasias</z:mp> using polyclonal and monoclonal antibodies to cyclin D1 protein </plain></SENT>
<SENT sid="3" pm="."><plain>Definite nuclear staining was seen in 15 of 15 MCLs, 1 of 7 B-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SLL</z:e>/CLLs, 0 of 7 reactive <z:mpath ids='MPATH_134'>hyperplasias</z:mpath>, 0 of 10 follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, and 0 of 4 <z:hpo ids='HP_0002665'>lymphomas</z:hpo> of mucosa-associated lymphoid tissue using immunoperoxidase stains on paraffin-embedded sections </plain></SENT>
<SENT sid="4" pm="."><plain>Best results were obtained with the affinity-purified polyclonal antibody on microwave-treated, formalin-fixed, paraffin-embedded tissue </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCLs</z:e> showed diffuse nuclear staining, whereas the one positive B-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SLL</z:e>/CLL showed dot-like or globular nuclear staining </plain></SENT>
<SENT sid="6" pm="."><plain>Nuclear cyclin D1 protein can be detected in <z:hpo ids='HP_0000001'>all</z:hpo> cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> and in rare cases of B-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SLL</z:e>/CLL using an immunohistochemical technique on formalin-fixed, paraffin-embedded tissue, and it does not appear to be detectable in reactive <z:mpath ids='MPATH_134'>hyperplasias</z:mpath> and other low-grade B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>This protein may be useful in subclassification of low-grade B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>